Baek-Yeol Ryoo Selected Research

Baek-Yeol Ryoo Research Topics

Disease

73	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 08/2010
51	Neoplasms (Cancer) 05/2024 - 11/2004
34	Stomach Neoplasms (Stomach Cancer) 01/2024 - 02/2008
20	Adenocarcinoma 02/2024 - 05/2011
16	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 01/2017
15	Neoplasm Metastasis (Metastasis) 05/2024 - 02/2008
15	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2017 - 01/2009
13	Disease Progression 02/2024 - 07/2008
12	Biliary Tract Neoplasms (Biliary Tract Cancer) 02/2023 - 02/2017
8	Hypertension (High Blood Pressure) 02/2024 - 07/2015
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2010 - 05/2004
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2024 - 01/2017
6	Cholangiocarcinoma 08/2023 - 06/2017
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2008 - 08/2005
5	Lymphatic Metastasis 11/2020 - 05/2011
4	Fibrosis (Cirrhosis) 12/2021 - 11/2011
4	Liver Neoplasms (Liver Cancer) 09/2021 - 11/2013
4	Liver Diseases (Liver Disease) 01/2021 - 07/2015
4	Lymphoma (Lymphomas) 04/2012 - 08/2005
3	Asthenia 02/2024 - 07/2015
3	Hepatic Encephalopathy 02/2024 - 01/2022
3	Venous Thromboembolism 01/2022 - 04/2017
3	Inflammation (Inflammations) 01/2022 - 01/2018
3	Neutropenia 11/2021 - 02/2015
3	Fatigue 11/2021 - 11/2013
3	Carcinoma (Carcinomatosis) 04/2021 - 07/2013
3	Diarrhea 01/2020 - 05/2018
3	Exanthema (Rash) 05/2018 - 02/2015
3	Pain (Aches) 01/2016 - 01/2008
2	Multiple Organ Failure (MODS) 02/2024 - 01/2022
2	Tumor Lysis Syndrome 02/2024 - 01/2022
2	Chemical and Drug Induced Liver Injury 02/2024 - 01/2022
2	Varicose Veins (Varicose Vein) 02/2024 - 01/2022
2	Hemorrhage 01/2022 - 03/2020
2	Hepatitis B 12/2021 - 11/2018
2	Margins of Excision 11/2020 - 01/2017
2	Thrombocytopenia (Thrombopenia) 01/2019 - 07/2015

Drug/Important Bio-Agent (IBA)

41	Sorafenib (BAY 43-9006)FDA Link 02/2024 - 08/2010
24	Gemcitabine FDA Link 02/2023 - 05/2004
23	Cisplatin (Platino)FDA LinkGeneric 02/2023 - 11/2004
17	Imatinib Mesylate (Gleevec)FDA Link 04/2017 - 01/2009
15	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021 - 04/2008
13	Biomarkers (Surrogate Marker)IBA 10/2023 - 04/2014
13	Capecitabine (Xeloda)FDA Link 01/2023 - 04/2008
10	regorafenibIBA 02/2024 - 04/2017
10	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 07/2008
9	folfirinoxIBA 02/2024 - 07/2017
9	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 01/2016
8	Leucovorin (Folinic Acid)FDA Link 01/2023 - 01/2016
8	ErbB Receptors (EGF Receptor)IBA 01/2010 - 08/2006
7	atezolizumabIBA 05/2024 - 01/2020
7	Bevacizumab (Avastin)FDA Link 05/2024 - 12/2016
7	cabozantinibIBA 03/2024 - 07/2018
7	lenvatinibIBA 01/2024 - 01/2020
7	pembrolizumabIBA 12/2023 - 01/2020
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2024 - 07/2015
6	Docetaxel (Taxotere)FDA Link 10/2021 - 01/2016
6	RamucirumabIBA 01/2018 - 07/2015
6	Gefitinib (Iressa)FDA Link 05/2010 - 08/2006
5	Immune Checkpoint InhibitorsIBA 03/2024 - 02/2023
4	Indicators and Reagents (Reagents)IBA 03/2024 - 09/2015
4	Tyrosine Kinase InhibitorsIBA 01/2024 - 10/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 07/2015
4	Trastuzumab (Herceptin)FDA Link 04/2021 - 03/2015
4	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2018
4	BilirubinIBA 08/2019 - 02/2008
4	Sunitinib (Sutent)FDA Link 04/2017 - 08/2011
3	NivolumabIBA 02/2024 - 07/2020
3	Alanine Transaminase (SGPT)IBA 02/2024 - 01/2020
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2024 - 01/2019
3	Phosphotransferases (Kinase)IBA 01/2022 - 11/2013
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022 - 07/2018
3	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 02/2007
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2021 - 10/2008
3	AntigensIBA 05/2020 - 01/2017
3	PlatinumIBA 08/2019 - 05/2004
3	Histone Deacetylase InhibitorsIBA 12/2018 - 04/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 05/2004
3	XELOXIBA 12/2016 - 04/2008
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2007 - 08/2006
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2024 - 12/2023
2	Chromogranin AIBA 07/2023 - 11/2020
2	enzalutamideIBA 03/2022 - 09/2021
2	AnticoagulantsIBA 01/2022 - 03/2020
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2020 - 01/2018
2	lanreotide (Somatuline)FDA Link 06/2020 - 01/2019
2	CA-19-9 Antigen (CA 19-9 Antigen)IBA 05/2020 - 11/2018
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2020 - 05/2017
2	Small Interfering RNA (siRNA)IBA 01/2019 - 03/2009

Therapy/Procedure

59	Therapeutics 05/2024 - 05/2002
45	Drug Therapy (Chemotherapy) 01/2023 - 11/2004
11	Adjuvant Chemotherapy 07/2023 - 08/2010
7	Radiotherapy 02/2022 - 07/2006
6	Neoadjuvant Therapy 03/2024 - 02/2019
5	Liver Transplantation 01/2023 - 08/2010
5	Gastrectomy 10/2021 - 10/2011
4	Combination Drug Therapy (Combination Chemotherapy) 08/2019 - 07/2008
3	Aftercare (After-Treatment) 01/2008 - 05/2004
2	Chemoradiotherapy 02/2022 - 01/2008
2	Immunotherapy 01/2022 - 01/2020